Moderately bullish activity in Pfizer (PFE), with shares up 82c, or 3.4%, near $25.07. Options volume running well above average with 169k contracts traded and calls leading puts for a put/call ratio of 0.38, compared to a typical level near 0.61. Implied volatility (IV30) is higher by 3.5 points near 20.47,in the lowest 10% of observations over the past year, suggesting an expected daily move of $0.32. Put-call skew flattened, suggesting a modestly bullish tone.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- PFE, NVS, and JNJ: The Shining Stars of the Sluggish Healthcare Sector
- Former Pfizer executive subpoenaed over alleged COVID vaccine delay, CNN reports
- Pfizer’s Sayana Press Study: Optimizing Drug Delivery for Better Outcomes
- Pfizer’s Promising Phase 3 Study on Prostate Cancer Treatment: A Potential Game Changer
- Pfizer’s Ngenla Study: A Long-Term Look at Growth Hormone Treatment